GSK recall sets Avandia deadline

GPs have until 21 October to take patients off diabetes drug rosiglitazone after manufacturer GSK issued a recall.

GSK has recalled Avandia diabetes drug tablets (Photograph: SPL)
GSK has recalled Avandia diabetes drug tablets (Photograph: SPL)

After this date, the rosiglitazone products Avandia and Avandamet will no longer be available in the UK. GSK said that all patients should be switched onto alternative treatments before this date.

A statement from GSK said: ‘In agreement with the MHRA, we believe that a 28-day period from the date of the EMA recommendation will be adequate for patients to be reviewed and transitioned to alternative treatments.’

GPs are advised to review all patients on the drugs as soon as possible and before this deadline.

Prescribers should not issue new or repeat prescriptions of rosiglitazone-containing medicines, said GSK.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus